Table 3.
Ischemic Strokes* | ||||||
Race | N | # ischemic stroke | Rate, %/yr (95% CI) | Rate difference (95% CI) | Unadjusted HR (95% Cl) | Adjusted† HR (95% Cl) |
White | 2058 | 145 | 1.50 (1.29, 1.77) | 0.97 (0.49, 1.46); p<0.001 | 1.00 (ref) | 1.00 (ref) |
Black | 1141 | 139 | 2.48 (2.10, 2.93) | 1.66 (1.31, 2.09) | 1.67 (1.30, 2.14) | |
Hemorrhagic Strokes* | ||||||
Race | N | # hemorrhagic stroke | Rate, %/yr (95% CI) | Rate difference (95% CI) | Unadjusted HR (95% CI) | Adjusted† HR (95% CI) |
White | 1934 | 21 | 0.22 (0.15, 0.34) | −0.07 (−0.21, 0.07); p=0.13 | 1.00 (ref) | 1.00 (ref) |
Black | 1010 | 8 | 0.15 (0.07, 0.30) | 0.69 (0.31, 1.55) | 0.72 (0.31, 1.70) |
For these analyses, we used the total number of incident AF cases and excluded those who had a stroke event prior to the diagnosis of AF. For the ischemic stroke analysis, we further excluded those who had a hemorrhagic stroke. Similarly, for the hemorrhagic stroke analysis, we excluded those participants who had an ischemic stroke event.
Adjusted for age, sex, smoking, hypertension, diabetes, obesity, heart failure, coronary heart disease, chronic kidney disease, vascular disease, aspirin and warfarin use.